9-95447229-C-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_000264.5(PTCH1):​c.4027G>A​(p.Gly1343Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000832 in 1,611,462 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G1343E) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000099 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000082 ( 1 hom. )

Consequence

PTCH1
NM_000264.5 missense

Scores

1
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:6

Conservation

PhyloP100: 2.41

Publications

7 publications found
Variant links:
Genes affected
PTCH1 (HGNC:9585): (patched 1) This gene encodes a member of the patched family of proteins and a component of the hedgehog signaling pathway. Hedgehog signaling is important in embryonic development and tumorigenesis. The encoded protein is the receptor for the secreted hedgehog ligands, which include sonic hedgehog, indian hedgehog and desert hedgehog. Following binding by one of the hedgehog ligands, the encoded protein is trafficked away from the primary cilium, relieving inhibition of the G-protein-coupled receptor smoothened, which results in activation of downstream signaling. Mutations of this gene have been associated with basal cell nevus syndrome and holoprosencephaly. [provided by RefSeq, Aug 2017]
PTCH1 Gene-Disease associations (from GenCC):
  • basal cell nevus syndrome 1
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • holoprosencephaly 7
    Inheritance: AD Classification: DEFINITIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • nevoid basal cell carcinoma syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, ClinGen, Orphanet, Labcorp Genetics (formerly Invitae)
  • holoprosencephaly
    Inheritance: AD Classification: LIMITED Submitted by: Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.011490732).
BP6
Variant 9-95447229-C-T is Benign according to our data. Variant chr9-95447229-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 41664.
BS2
High AC in GnomAd4 at 15 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000264.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PTCH1
NM_000264.5
MANE Select
c.4027G>Ap.Gly1343Arg
missense
Exon 23 of 24NP_000255.2Q13635-1
PTCH1
NM_001083603.3
MANE Plus Clinical
c.4024G>Ap.Gly1342Arg
missense
Exon 23 of 24NP_001077072.1Q13635-2
PTCH1
NM_001354918.2
c.3871G>Ap.Gly1291Arg
missense
Exon 22 of 23NP_001341847.1A0A1W5YLI7

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PTCH1
ENST00000331920.11
TSL:5 MANE Select
c.4027G>Ap.Gly1343Arg
missense
Exon 23 of 24ENSP00000332353.6Q13635-1
PTCH1
ENST00000437951.6
TSL:5 MANE Plus Clinical
c.4024G>Ap.Gly1342Arg
missense
Exon 23 of 24ENSP00000389744.2Q13635-2
PTCH1
ENST00000429896.6
TSL:1
c.3574G>Ap.Gly1192Arg
missense
Exon 23 of 24ENSP00000414823.2Q13635-4

Frequencies

GnomAD3 genomes
AF:
0.0000986
AC:
15
AN:
152188
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00346
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000134
AC:
33
AN:
245858
AF XY:
0.000127
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000290
Gnomad ASJ exome
AF:
0.00221
Gnomad EAS exome
AF:
0.000165
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000454
Gnomad OTH exome
AF:
0.000331
GnomAD4 exome
AF:
0.0000815
AC:
119
AN:
1459274
Hom.:
1
Cov.:
30
AF XY:
0.0000785
AC XY:
57
AN XY:
725998
show subpopulations
African (AFR)
AF:
0.0000598
AC:
2
AN:
33470
American (AMR)
AF:
0.0000447
AC:
2
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00233
AC:
61
AN:
26130
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39696
South Asian (SAS)
AF:
0.000104
AC:
9
AN:
86238
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52308
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5764
European-Non Finnish (NFE)
AF:
0.0000306
AC:
34
AN:
1110604
Other (OTH)
AF:
0.000133
AC:
8
AN:
60340
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
9
18
26
35
44
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000986
AC:
15
AN:
152188
Hom.:
0
Cov.:
32
AF XY:
0.0000403
AC XY:
3
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41464
American (AMR)
AF:
0.00
AC:
0
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00346
AC:
12
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4838
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10632
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68004
Other (OTH)
AF:
0.000478
AC:
1
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000141
Hom.:
0
Bravo
AF:
0.000125
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00
AC:
0
ExAC
AF:
0.000125
AC:
15
EpiCase
AF:
0.000164
EpiControl
AF:
0.000119

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Gorlin syndrome (2)
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
1
-
Holoprosencephaly 7 (1)
-
1
-
not provided (1)
-
-
1
not specified (1)
-
-
1
PTCH1-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.37
CADD
Benign
18
DANN
Benign
0.90
DEOGEN2
Benign
0.17
T
Eigen
Benign
-0.50
Eigen_PC
Benign
-0.36
FATHMM_MKL
Benign
0.70
D
LIST_S2
Uncertain
0.88
D
M_CAP
Benign
0.025
T
MetaRNN
Benign
0.011
T
MetaSVM
Benign
-0.46
T
MutationAssessor
Benign
0.81
L
PhyloP100
2.4
PrimateAI
Benign
0.39
T
PROVEAN
Benign
0.14
N
REVEL
Benign
0.20
Sift
Benign
0.17
T
Sift4G
Benign
0.77
T
Polyphen
0.0020
B
Vest4
0.11
MutPred
0.25
Gain of methylation at G1343 (P = 0.0351)
MVP
0.25
MPC
0.17
ClinPred
0.050
T
GERP RS
5.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.046
gMVP
0.23
Mutation Taster
=75/25
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200100952; hg19: chr9-98209511; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.